Publication | Open Access
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
1.5K
Citations
30
References
2005
Year
ObesityMetabolic SyndromeCannabis UseCardiovascular DiseaseHealth PolicyObesity ManagementWeight ManagementWeight ReductionMedicineCannabinoid PharmacologyRio-europe StudyOverweight PatientsHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1